Increased Incidence of New-Onset Diabetes Mellitus Type II Following Haploidentical Bone Marrow Transplant with Post-Transplant Cyclophosphamide for Sickle Cell DiseaseDilan A. Patel, Adetola A. Kassim, Josu de la Fuente et al.|Blood|2020Cited by 0
Reduction in Prevalence of Thrombotic Events in Sickle Cell Disease after Allogeneic Hematopoietic Stem Cell TransplantationAmeet Patel, Adetola A. Kassim, Karina L Wilkerson et al.|Blood|2020Cited by 0
Incidence and Outcomes of Early Fever Following Haploidentical Hematopoietic Cell Transplant with Post-Transplant CyclophosphamideKatie S. Gatwood, Adetola A. Kassim, Jacquelyn Day et al.|Transplantation and Cellular Therapy|2021Cited by 0
Evaluating the Clinical Benefit of Post-Transplant DNA Methyltransferase Inhibitor (DNMTi) Maintenance in MDS/AMLLindsay Orton, Kathryn A. Culos, Adetola A. Kassim et al.|Transplantation and Cellular Therapy|2021Cited by 0